| Astellas Finally Joins Peers With Major Overseas Acquisition EP Vantage submits:To coin a L’Oréal phrase, in the eyes of Astellas Pharma (ALPMF.PK), OSI Pharmaceuticals (OSIP) is definitely ‘worth it’. Having conducted its due diligence of OSI’s private books, Astellas Sunday raised its original hostile offer of $52 cash per share to an accepted bid of $57.50 cash per share, valuing the deal at $4bn, the second biggest overseas acquisition by a Japanese pharma company.Big sighs of relief all round then at Astellas, who failed to land CV Therapeutics last year and adopted a slightly risky approach to bidding for OSI. But it now looks set to increase its presence in the US market and gain a portfolio of marketed and pipeline cancer drugs, most notably lung cancer drug Tarceva. As for OSI, some ambitious shareholders will be disappointed with the price as the stock reached $59.80 on Friday, but given that the offer is a 55% premium overall and equivalent to a five-year high, they should be more than happy.Complete Story » seekingalpha.com |
FDA to Weigh Consumer Genetic Tests A high bar is likely to be set for companies seeking to sell genetic tests directly to consumers, according to top FDA officials. online.wsj.com |
Obesity in Pregnancy Is Risky for Babies A large new study offers some of the most direct evidence yet that mothers who gain more weight during pregnancy have larger babies who are at greater risk of obesity in adulthood. online.wsj.com |
Quest Diagnostics to Release Third Quarter 2010 Financial Results [PR Newswire] - Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, announced today that it will report third quarter 2010 results on Wednesday, October 20, before the market opens. us.rd.yahoo.com |
Genoptix Ranked 41st Fastest-Growing Company in North America on Deloitte's 2010 Technology Fast 500 [PR Newswire] - Genoptix, Inc. , a specialized laboratory services provider, today announced that it ranked number 41 on Technology Fast 500â„¢, Deloitte's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. us.rd.yahoo.com |